Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
United BioPharma (UBP) announced today that the U.S. Food and Drug Administration (FDA) has approved a phase 2 clinical trial IND submitted by the...
United BioPharma (UBP) today announced their latest results featuring unprecedented and unique functional characteristics of UB-221 monoclonal...
Taiwan-based United BioPharma (UBP) has announced the approval of a Phase 2 clinical trial with novel anti-IgE monoclonal antibody UB-221 by the...
United BioPharma announced today that Shanghai Public Health Clinical Centre and Cheng Kung University's Department of Microbiology and Immunology...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.